Compare Enveric Biosciences Inc (ENVB) vs ProShares UltraPro Short QQQ ETF (SQQQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs ProShares UltraPro Short QQQ ETF — how do they compare? Enveric Biosciences Inc trades at $1.45 (market cap $6.20M), while ProShares UltraPro Short QQQ ETF trades at $36.88. Which is the better fit depends on your goals.
| ENVB | SQQQ | |
|---|---|---|
Market Cap | $6.20M | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $17.40 | $92.95 |
52-Week Low | $1.27 | $36.31 |
Enterprise Value | $1.30M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About ProShares UltraPro Short QQQ ETF
SQQQ is a leveraged inverse ETF that seeks daily investment results, before fees and expenses, that correspond to three times the inverse (-3x) of the daily performance of the Nasdaq-100 Index. It is a tactical trading tool designed for sophisticated investors to profit from or hedge against declines in large-cap technology and growth stocks. Due to its daily reset and the effects of compounding, it is intended for short-term use and carries significant risk if held during periods of high market volatility.
Read more on SQQQ →
